CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

The Role of Pharmaceutical Wholesalers in the Drug Industry

The Role of Pharmaceutical...

Technology-driven Innovations To Stimulate the Capability in Agricultural Practices

Technology-driven Innovations To...

The Life Science Marketing To Accelerate In the Future With Tech-driven Genetics Innovations

The Life Science Marketing To...

Singapore Among the Top Life Science Hubs in APAC

Singapore Among the Top Life Science...

Emerging Life Science Trends in 2023

Emerging Life Science Trends in 2023

Emerging Life Science Marketing and Industry Trends for 2023

Emerging Life Science Marketing and...

The Vital Role of CROs in the Drug Development Journey

The Vital Role of CROs in the Drug...

CRO Consolidation to Bring New Developments to Clinical Trials

CRO Consolidation to Bring New...

The Role of Pharmaceutical Wholesalers in the Drug Industry

The Role of Pharmaceutical...

Technology-driven Innovations To Stimulate the Capability in Agricultural Practices

Technology-driven Innovations To...

The Life Science Marketing To Accelerate In the Future With Tech-driven Genetics Innovations

The Life Science Marketing To...

Singapore Among the Top Life Science Hubs in APAC

Singapore Among the Top Life Science...

Emerging Life Science Trends in 2023

Emerging Life Science Trends in 2023

Emerging Life Science Marketing and Industry Trends for 2023

Emerging Life Science Marketing and...

The Vital Role of CROs in the Drug Development Journey

The Vital Role of CROs in the Drug...

CRO Consolidation to Bring New Developments to Clinical Trials

CRO Consolidation to Bring New...

How a Single Unified Data Platform Can Optimize Multiple Workloads

Life Sciences Review | Wednesday, January 06, 2021
Tweet

The expanded agility of a self-service, single data platform for all market customers provides profound advantages for the three major pharma teams in industrial, medical, and clinical activities.


FREMONT, CA: Nowadays, more businesses know that it is easier to own the data platform that pharma teams require instead of relying on outsiders. One firm predicted that next year, end consumers who have access to a curated data catalog would benefit twice as much from analytics as they do not.


In 2021, small and medium-sized life science firms will own their data systems to enable self-service connectivity and market mobility when they are most required. Underpinned by a shared data paradigm, this centralized data architecture is a cost-effective approach that offers an exact point of reality for all data—and uses cases—through business lines.


The expanded agility of a self-service, single data platform for all market customers provides profound advantages for the three major pharma teams in industrial, medical, and clinical activities. Collectively, it allows quicker reactions to evolving market conditions—like those created by COVID-19—for faster revisions and timely changes to business rules and KPIs to change launch cycles.


Instead of tracing together Individual components for computer engineering pipelines such as Extract, Transform, Load (ETL), and data quality software, companies can exploit a single investment in a centralized data framework that can be replicated by their various departments. Since a similar data model drives this approach, both agencies will use the same institutions for their respective purposes.


For a traditional patient-like entity, clinical surgery teams can use a model to monitor how many patients participated in the experiment, how many completed, what treatments they took, and how many were healed. Medical teams will review the same organization's analytics on all clinical trials' synopsis, providing them with information on the demographics of the treatment and the success rate to guide discussions with key opinion-makers. Commercial departments will analyze the same entity to reach patients and their physicians. As a substitute of monitoring these indicators with various tools, companies should use this centralized framework's shared data architecture with different predictive dashboards, which is far more cost-effective.


Weekly Brief

loading
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/how-a-single-unified-data-platform-can-optimize-multiple-workloads-nwid-224.html